Digital watermarks can determine if volumetric medical images have been altered by hackers or other parties, and what areas have been affected.
Digital watermarks can determine if volumetric medical images have been altered by hackers or other parties, and what areas have been affected, according to an article published online in the Journal of Digital Imaging.
While tampering of medical images may not cross the minds of many, the increasing use of web-based technology for patient records and the transmission of records over the Internet could leave images vulnerable to hackers, researchers say. Alteration of medical images sent for consultation could result in incorrect diagnosis and treatment of patients.
To reduce the risk of tampering of images occurring, researchers from Nanyang Technological University in Singapore have developed a fully reversible, dual-layer watermarking scheme with tamper detection capability.
The researchers sought to use 3D properties of the volumetric images rather than the previously used 2D techniques. They used public-key cryptography and reversible data-hiding technique to develop their concept of vertical watermarking. If an image has been altered, the altered regions will be highlighted when viewed at the receiving end. The scheme was tested using medical images in DICOM format, as well as against a previously used 2D application. According to the study, there was 100 percent tamper localization accuracy with the newer 3D technique.
The time involved in de-watermarking images is important. This new technique yielded an average reduction of 65 percent in watermarking time and a 72 percent in de-watermarking time for tested images, compared with the 2D technique.
“The results show that the scheme is able to ensure image authenticity and integrity, and to locate tampered regions in the images,” concluded the authors. More research is to follow as the technique is tested in a clinical environment.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.